How does Sitagliptin impact HbA1c levels in patients with poorly controlled diabetes, and what improvements can be expected with consistent use?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Sitagliptin effectively lowers HbA1c by about 0.5 to 0.8% in patients with poorly controlled type 2 diabetes when used consistently over several months.